PACIRA BIOSCIENCES, INC. Current Assets
PACIRA BIOSCIENCES, INC. (PCRX) had Current Assets of $615.22 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-04
- 2026-06-30: Assets, Current $615.22M.
- 2026-03-31: Assets, Current $514.96M.
- 2025-12-31: Assets, Current $547.97M.
- 2025-09-30: Assets, Current $562.75M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $615.22M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $514.96M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $547.97M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $562.75M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $745.61M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $759.96M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $745.13M 10-K · filed 2026-02-26 |
| 2024-09-30 | $689.97M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $632.21M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $543.11M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $509.99M 10-K · filed 2025-02-27 |
| 2023-09-30 | $447.25M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $429.32M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $376.11M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $498.33M 10-K · filed 2024-02-29 |
| 2022-09-30 | $533.41M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $526.21M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $667.02M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $866.05M 10-K · filed 2023-02-28 |
| 2021-09-30 | $822.35M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $792.58M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $720.25M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $651.62M 10-K · filed 2022-02-28 |
| 2020-09-30 | $658.52M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $455.82M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $431.59M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $408.56M 10-K · filed 2021-03-01 |
| 2019-09-30 | $378.85M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $394.61M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $508.67M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $477.97M 10-K · filed 2020-02-21 |
| 2018-09-30 | $472.05M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $455.05M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $418.73M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $391.11M 10-K · filed 2019-02-28 |
| 2017-09-30 | $365.83M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $450.99M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $447.96M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $243.09M 10-K · filed 2018-02-28 |
| 2016-09-30 | $235.44M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $257.99M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $248.63M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $252.58M 10-K · filed 2017-03-01 |
| 2015-09-30 | $233.10M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $229.63M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $219.75M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $214.26M 10-K · filed 2016-02-25 |
| 2014-09-30 | $199.24M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $208.91M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $98.48M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $106.75M 10-K · filed 2015-02-24 |
| 2013-09-30 | $111.69M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $121.49M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $128.99M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $60.92M 10-K · filed 2014-02-25 |
| 2012-09-30 | $85.13M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $100.08M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $62.26M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $82.65M 10-K · filed 2013-03-07 |
| 2011-09-30 | $43.40M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $53.60M 10-Q · filed 2011-08-11 |
| 2010-12-31 | $31.05M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |